AzTrials
AzTrials

Teaching TechniquePhase 3ELBPSNCT01249586

E-learning: Teaching of Blindness Prevention

A Phase 3 study testing E-learning in people with Teaching Technique, run by Clinica Oftamologica Zona Sul at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

E-learning material increases the student knowledge level before the traditional class of blindness prevention and help to fix this information a short period (one month) after the class. Read more about this study

Who is it for?
Ages 18 to 40 years
Conditions the study is for
Teaching Technique
What is being tested?
E-learning
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
Not given
Where
1 siteBrazil
Study dates
Feb 2010to Oct 2010
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Adult

Who may be able to join

  • being a medical student matriculated in the course of ophthalmology. This course is taught to fourth-year students at State University of Campinas.

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Clinics Hospital of the State University of Campinas

    Campinas, São Paulo, 6111

Other trials in Brazil

About this study

Official title: E-learning as a Complement to Traditional Teaching of Blindness Prevention

E-learning material increases the student knowledge level before the traditional class of blindness prevention and help to fix this information a short period (one month) after the class.

Being tested
E-learning

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • E-learningOther

    A traditional class of blindness prevention plus an additional e-learning material. The e-learning material included a PDF article about blindness prevention. This material was e-mailed one week before the traditional class.

Study groups in NCT01249586
Study groupRoleWhat they receive
Traditional teachingPlacebo comparatorA traditional class of blindness prevention.
Receives: Other: E-learning

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Immediate pretest score

Secondary outcomes (2)
  1. One-month posttest score

  2. Immediate posttest score.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Nov 2010 (estimated)
  2. Study startFeb 2010
  3. Primary completionOct 2010
  4. Study completionOct 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
IDs, dates and publications
ClinicalTrials.gov ID
NCT01249586
Sponsor's protocol ID
ELBPS
Acronym
ELBPS
Status last verified
Nov 2010
First submitted
29 Nov 2010
Last updated
30 Nov 2010
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing E-learning in people with Teaching Technique, run by Clinica Oftamologica Zona Sul at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Nov 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Immediate pretest score. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Nov 2010.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in